Free eBook explores common approaches to data warehousing

Laura Pedulli | | Health Exec | EMR/EHR

Thanks to EHR adoption, an increasing number of hospitals are shifting their IT priorities toward systems like the enterprise data warehouse, which mines the EHR for insights to improve care and lower cost.

Health Catalyst, a Utah-based consulting group, has released a free eBook that explores common approaches to data warehousing in healthcare, mistakes to avoid and real-world examples of healthcare organizations that have used their data warehouse to improve operational efficiency and quality of care while increasing ROI. 

"If you're going to achieve high performance analytics, the EHR alone won't cut it," wrote co-author Dale Sanders, senior vice president of strategy for Health Catalyst. "You need an enterprise data warehouse. In fact, there is no viable technical alternative to an enterprise data warehouse if you want to successfully use analytics to improve the longitudinal cost and quality of care."

Read the eBook here.

Laura Pedulli

Related Content

Christmas ransomware exposed over 300K patient records to dark web
Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software
Leveraging machine learning to rapidly create clinical AI algorithms
How medication reconciliation data consolidation in the EHR enables better patient care

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.